|
|
|
|
BextraOpen PR (press release), ...(openPR) - Website publishes critical information about Bextra, a medicine that is the cause of many lawsuits. ARIZONA, "Bextra ... Health Canada bans Bextra Jan 11, 2006 Quesnel Cariboo Observer, By Alain Saffel. Health Canda has decided to ban the anti-inflammatory drug Bextra after reviewing the safety information on the arthritis and pain drug. ... Brown & Crouppen file Bextra suit in St. Clair County Jan 3, 2006 Madison County Record, Pfizer's recalled prescription medication Bextra is the subject of another lawsuit filed in St. ... Bextra is a Cox-2 inhibitor and was approved by the FDA on Nov. ... Canada bans Pfizer arthritis drug Bextra Dec 16, 2005 Reuters Canada, OTTAWA (Reuters) - Canada banned Pfizer Inc.'s arthritis drug Bextra on Friday because of risks of heart attacks and strokes. Bextra ... Bextra's return barred by Health Canada Dec 17, 2005 London Free Press, By CP. TORONTO -- The painkiller Bextra will not be allowed back on the Canadian market, Health Canada announced yesterday. In barring ... Health Canada won't allow Bextra back on shelves Dec 16, 2005 CTV.ca, TORONTO — The painkiller Bextra will not be allowed back on the Canadian market, Health Canada announced Friday. In barring the ... Canada says Bextra drug will not return to market Dec 16, 2005 Reuters Canada, OTTAWA (Reuters) - Pfizer Inc.'s arthritis drug Bextra, which it voluntarily suspended in April, will not return to the Canadian market, the federal government ... Bextra not to be sold in Canada: ruling Dec 17, 2005 National Post, Health Canada is following the advice of an expert panel that concluded Bextra should not be sold in Canada. Bextra is a member ... Advisory - Health Canada prohibits sale of Bextra in Canada Dec 16, 2005 Canada NewsWire (press release), 16 /CNW Telbec/ - Following a review of safety information, Health Canada is informing the public that Bextra, an anti-inflammatory drug used to treat ... Health Canada Prohibits Sale of Bextra in Canada Dec 16, 2005 DG News OTTAWA, CANADA -- December 16, 2005 -- Following a review of safety information, Health Canada is informing the public that Bextra, an anti-inflammatory drug ... Advisory - Health Canada Prohibits Sale of Bextra in Canada Dec 16, 2005 Halifax Live, Following a review of safety information, Health Canada is informing the public that Bextra, an anti-inflammatory drug used to treat arthritis and pain, will ... Health Canada Bans Sale of Bextra Dec 18, 2005 Newsinferno.com, Pfizer has announced Celebrex is about to undergo new safety testing while the company’s other COX-2 inhibitor, Bextra, was removed from the market in April ... Bextra is latest cox-2 drug to be barred in Canada Dec 16, 2005 Hamilton Spectator (subscription), The painkiller Bextra will not be allowed back on the Canadian market, Health Canada announced yesterday. In barring the return ... Pfizer Canada statement regarding Bextra Dec 16, 2005 CNW Telbec (Communiqués de presse), 16 /CNW/ - Pfizer Canada said today it is disappointed with Health Canada's decision not to allow Bextra (valdecoxib) to return to the Canadian market under ... Canada May Not Permit Bextra To Reenter Market Dec 18, 2005 MedIndia, Health Canada has announced a ban on the anti-inflammatory drug Bextra, meant for those who suffer from arthritis. The benefits ... People's Pharmacy: Anti-inflammatory drugs may cause ... Jan 14, 2006 Bryan College Station Eagle, Drugs like Vioxx, Celebrex and Bextra were supposed to ease pain without causing the gastrointestinal problems associated with traditional NSAIDs. ... Ban remains on painkiller Bextra Dec 17, 2005 Edmonton Sun, By CP. TORONTO -- The painkiller Bextra will not be allowed back on the Canadian market, Health Canada announced yesterday. Bextra ... Investors can't swallow Genentech news Jan 11, 2006 CNN/Money New York Stock Exchange. Copycats like Lipitor can make billions, or fail like Vioxx and Bextra. (Full story). Patent losses can ... News and views Jan 10, 2006 The South African Journal of Natural Medicine (subscription), Vioxx has already been taken off the market, followed by Bextra, and even Celebrex is being fingered. None of this is surprising. ... Largest/Most Diverse Pipeline: Pfizer Jan 10, 2006 R&D Directions (subscription), ...emphasis on developing replacements. Under attack are market giants Lipitor, Viagra, Bextra, and Celebrex. Pfizer also strives to ... People's Pharmacy: Asthma drugs require caution Jan 7, 2006 Bryan College Station Eagle, Is he really in danger? I've taken other drugs that have been pulled off the shelves: Vioxx and Bextra. Now I'm wondering about Advair. What's going on? ... J&J: deaths unreported in drug study Jan 3, 2006 CNN/Money ...other parts of the body. Copycats like Lipitor can make billions, or fail like Vioxx and Bextra. (Full story). The company on Tuesday ... Health officials won't revive arthritis drug Dec 16, 2005 Toronto Star, Bextra, an anti-inflammatory drug for arthritis sufferers, will not be allowed back on the Canadian market. Based on recommendations ... DR. JOHNSON'S HEALTHY LIVING NEWSLETTER Jan 2, 2006 Free Market News Network, An expert panel has concluded Bextra should not be sold in Canada and Health Canada is listening. The advisory committee requested ... Fayetteville woman files pain-drug suit Dec 21, 2005 Arkansas Democrat-Gazette (subscription), FAYETTEVILLE — A Fayetteville woman filed a lawsuit Tuesday against a national drug company saying that the pain medication Bextra she took caused her to ... Strange Goings On at the Cleveland Clinic: Mere Coincidences or ... Dec 19, 2005 Newsinferno.com, ...on the US market, the multi-billion dollar blockbuster will either have the field to itself or be declared no worse than its sister-drugs Vioxx and Bextra. ... Merck Refills its Prescription Dec 15, 2005 Red Herring, The Whitehouse Station, New Jersey-based company was forced to recall Vioxx earlier this year, as did Pfizer with its pain treatment Bextra (see Pfizer Yanks ... Ottawa bans arthritis drug Dec 16, 2005 CBC News, Sales of Bextra have been suspended since last April when the federal government approached its maker, Pfizer Inc., after concerns were raised in the United ... Whiny Whistleblower of the Year Award Dec 30, 2005 American Council on Science and Health, Graham has made a career out of calling for the banning of drugs, including Accutane, Arava, Meridia, Serevent, and Bextra. All ... Stem Cell Project Scandal Is Disturbing but Hardly an Uncommon ... Dec 25, 2005 Newsinferno.com, Of the 32 government drug advisers who would vote on the issue, 10 had consulted for Merck (Vioxx) or Pfizer (Celebrex and Bextra) in recent years.While the ... Court Rules for Pfizer in Lipitor Patent Case Dec 17, 2005 All Headline News ...safety concerns. Revenue from Bextra was eliminated when the drug was withdrawn after being linked to a deadly skin condition. Lipitor ... Matthew Herper On The Drug Industry Dec 27, 2005 Forbes Vioxx set the stage for further controversies involving drugs such as Pfizer's (nyse: PFE - news - people ) pain pill Bextra, Natrecor, a Johnson & Johnson ... Celebrex's Toughest Trial Dec 15, 2005 TIME A competitor made by Pfizer, Bextra, was yanked some months later, leaving only Pfizer's Celebrex behind—and a new, required safety warning hasn't exactly ... FDA, safety and politics enmeshed Dec 26, 2005 USA Today Safety concerns led to the withdrawal of two popular arthritis drugs: Vioxx in September 2004 and Bextra in April of this year. ... Supplements help mend, not mask, pain Dec 20, 2005 Newsday, When top prescription pain relievers (like Vioxx or Bextra) are pulled from the market because of fatalities, and serious doubts shroud Celebrex and other ... Lipitor Patent Win Boosts Pfizer Shares Dec 19, 2005 Leading The Charge, ...heart problems. Meanwhile, earlier this year, Pfizer withdraw Bextra , another drug in the class, because of safety concerns. And ... Pfizer sponsors major Celebrex safety study Dec 15, 2005 Pharma Times (subscription), Celebrex is the last remaining COX-2 inhibitor on the market, after Merck & Co's Vioxx (rofecoxib) and Pfizer's Bextra (valdecoxib) were withdrawn from sale ... Dosage is key with acetaminophen Dec 16, 2005 Biloxi Sun Herald, A: Acetaminophen (Tylenol and other brands) is very safe when used properly. The Vioxx you took is a COX-2 NSAID (others are Bextra and Celebrex). ... Top medical stories of 2005 Dec 30, 2005 WHDH-TV, Yet another arthritis drug bit the dust - Bextra was pulled after the FDA noted the medicine was no better than a similar drug Celebrex, and was more likely to ... Clinical trial on painkillers Dec 20, 2005 The News Journal, ...of NSAIDs. Two other cox-2 painkillers, Vioxx and Bextra, have been pulled off the market because of documented heart risks. "The ... Pfizer is getting an overdose of generics Jan 8, 2006 Sun-Sentinel.com, Sales of Pfizer's Celebrex painkiller have fallen by more than half, and Pfizer had to withdraw a related drug, Bextra, from the market last April at the FDA's ... Clinic-led trial to look at safety of painkillers Dec 14, 2005 Cleveland Plain Dealer, Concerns also have been raised about Pfizer's Celebrex and Bextra. ... The drug maker withdrew Bextra from the market earlier this year. ... Scientists plan huge painkiller risk study Dec 14, 2005 Boston Globe, The study comes after the withdrawal of Vioxx and Bextra from the market, and the Food and Drug Administration's addition of warnings on other painkiller labels ... The Cox-2 Controversy: Health Risks of Arthritis Drugs Dec 13, 2005 The Lookout News, Pain relievers like Vioxx, Celebrex, and Bextra belong to a class of drugs known as Cox-2 inhibitors, which have been linked to a higher risk of cardiovascular ... Painkillers to get safety check Dec 14, 2005 News & Observer, ...the burden is upon us to do this right." Drug safety and the credibility of research have been concerns in recent months since Vioxx and Bextra were pulled ... Genes explain some heart risk from COX drugs: study Jan 4, 2006 ABC News In April, Pfizer Inc. suspended sales of its COX-2 inhibitor Bextra and now includes a strong "black box" warning for its COX-2 Celebrex. ... ADHD Drug Cardiac Events, COX-2s Are Topics For Drug Safety ... Jan 5, 2006 FDA Advisory Committee ...of increased cardiovascular events with COX-2 selective agents led to the market withdrawal of Merck Vioxx in September 2004 and Pfizer’s Bextra in April. ... Pfizer funds $100M painkiller safety study Dec 15, 2005 myDNA.com, This study is most likely prompted by Merck pulling its Cox-2 inhibitors Vioxx and Bextra off store shelves, when they were linked to cardiovascular deaths ... Glaxo, FDA still in talks on Cervarix Jan 3, 2006 CNN/Money ...agency are still ongoing. Copycats like Lipitor can make billions, or fail like Vioxx and Bextra. (Full story). "Discussions with the ... The Year in Review 2005 — Timeline of notable business news ... Dec 31, 2005 San Antonio Express (subscription), 2.50 percent. 18 — Experts vote to tell Food and Drug Administration to allow Celebrex, Bextra and Vioxx to stay on market. 28 ... Penn Researchers Call for New Paradigm in Clinical Trials ... Jan 5, 2006 AScribe ...comprehensively the basic and clinical evidence that explains how drugs like rofecoxib (Vioxx), celecoxib (Celebrex), and valdecoxib (Bextra) confer a small ... Penn researchers call for new paradigm in clinical trials Jan 5, 2006 EurekAlert (press release), ...comprehensively the basic and clinical evidence that explains how drugs like rofecoxib (VIOXX), celecoxib (CELEBREX), and valdecoxib (BEXTRA) confer a small ... New Canadian arthritis treatment recommendations released Jan 4, 2006 Canada NewsWire (press release), ...including selective COX-2 inhibitors or coxibs) among patients with OA and rheumatoid arthritis (RA) following the withdrawal of Vioxx(R) and Bextra(R) from ... Whirled Peas Jan 4, 2006 Neosho Daily News, Imagine my surprise when I got one from a law firm asking if I'd ever taken Bextra, Celebrex or Vioxx and experienced any number of side effects, including ... Pfizer to Finance $100 Million Safety Study of Celebrex Dec 13, 2005 New York Times, ...risk of heart attacks and strokes. Since then, a Pfizer cox-2 drug, Bextra, has also been withdrawn. "We're certainly very pleased ... Study to look at pain relievers in heart patients Dec 14, 2005 Chicago Sun-Times, Drug safety and the credibility of research have been concerns in recent months since Vioxx and Bextra were pulled from the market because of evidence they can ... Researchers plan large-scale study on safety of painkillers Dec 13, 2005 WLNS, That confidence suffered as Vioxx and Bextra were pulled from the market because of evidence they can raise the risk of a heart attack or stroke. ... Cleveland Clinic to head study of pain relievers Dec 13, 2005 WKYC-TV, Drug safety and the credibility of research have been concerns in the months since arthritis pain relievers Vioxx and Bextra were pulled from the market ... Pfizer to fund independent trial on Celebrex and heart risks Dec 14, 2005 News-Medical.net, At present Celebrex is the only cox-2 inhibitor still on the market as both Vioxx and Bextra were withdrawn in 2004 over concerns of cardiovascular risks. ... Study on Safety of Pain Killers Dec 14, 2005 WLNS, Drugs like Vioxx, Bextra and Celebrex became popular because they were gentler on the stomach than older pain relievers, but those drugs have been at the ... Viagra takes aim at knock offs Jan 6, 2006 CNN ...counterfeit our products.". Copycats like Lipitor can make billions, or fail like Vioxx and Bextra. (Full story). Pfizer (Research ... Court rules for Pfizer in Lipitor patent case Dec 17, 2005 Reuters South Africa, Celebrex arthritis drug, meanwhile, have been cut almost in half due to safety concerns, and revenue from Pfizer's newer arthritis drug Bextra vanished when it ... Pfizer Wins Patent Case, Staves Off Generic Version of Lipitor Dec 17, 2005 Los Angeles Times, Pfizer's Celebrex arthritis drug, meanwhile, have been cut almost in half because of safety concerns, and revenue from the arthritis drug Bextra vanished when ... Pfizer Plans Study of 20,000 Patients on Risks of Celebrex Dec 13, 2005 New York Times, ...strokes. Since then, the Pfizer cox-2 drug Bextra was also taken off the market at the Food and Drug Administration's request. "We ... Lipitor patent win boosts Pfizer shares Dec 19, 2005 BusinessWeek ...heart problems. Meanwhile, earlier this year, Pfizer withdraw Bextra, another drug in the class, because of safety concerns. Sales ... Bird Flu, Cloning, Katrina: Top Health Stories of 2005 Dec 27, 2005 FOX News ...thought? Those days ended this year. Previously underappreciated heart risks forced Vioxx, and then Bextra, off the market. That ... Bird Flu Threat Tops Health News for '05 Dec 29, 2005 Forbes A second cox-2, Pfizer's Bextra, was pulled from drugstore shelves in April after long-term use was linked to cardiovascular dangers. ... Pfizer shares jump 8 percent Dec 20, 2005 News & Observer, This year, Pfizer withdraw Bextra, another drug in the class, because of safety concerns Sales of erectile dysfunction drug Viagra dropped 4 percent to $386 ... Killer flu worries, lack of vaccine dominated medical news Dec 28, 2005 Billings Gazette, Merck's withdrawal of the popular arthritis medication Vioxx from the market in September 2004 was followed in March by Pfizer's withdrawal of Bextra. ... Protocol of convenience Dec 19, 2005 Baltimore Sun, Clinic published an analysis questioning the safety of not only Vioxx, but also the entire class of so-called Cox-2 inhibitors (Celebrex and Bextra are the ... Leawood pharmaceutical exec faces more charges Dec 14, 2005 Kansas City Business Journal, ...in California, secret commissions and kickbacks in connection with NuCare's alleged contract to import allegedly repackaged Bextra and Lipitor. ... Mendelsohn vacates Moran's transfer Dec 29, 2005 St. Clair Record, ...of Pontoon Beach and Mike Baldwin of Smithton claim that Pfizer's false and misleading statements inflated the value of pain relievers Celebrex and Bextra. ... Business year in review 2005 Dec 25, 2005 NorthJersey.com, ...campus. 7 Pfizer Inc. pulls its pain medicine Bextra from the market at the request of the US Food and Drug Administration. At the ... Cato In the Media Dec 28, 2005 Cato Institute, ...to two years, was marked by controversy: [1.] Safety concerns led to the withdrawal of two popular arthritis drugs: Vioxx in September 2004 and Bextra in April ... DR. JOHNSON'S HEALTHY LIVING NEWSLETTER Dec 15, 2005 Free Market News Network, Why are dietary supplements being singled out for scrutiny when Vioxx, Celebrex and Bextra produce more serious side effects and have killed thousands of ... On medical news, is the reporting healthy? Dec 29, 2005 Globe and Mail, ...(The arrival of cox-2 inhibitors, a form of painkiller sold under brand names such as Vioxx, Celebrex and Bextra, was greeted with almost universally fawning ... Pick the Right Pain Pill Dec 17, 2005 U.S. News & World Report Advil, Motrin, Aleve): This class of drugs, which includes ibuprofen and naproxen, got a lot of bad press this year after Pfizer pulled Bextra, a prescription ... Saving Celebrex Dec 13, 2005 Forbes ...firestorm. As more data came to light, studies also linked Celebrex to a heart risk, and Pfizer's Bextra was pulled from the market. ... Study to test safety of painkillers on heart patients Dec 13, 2005 USA Today After that study, Vioxx and its chemical cousin Bextra were taken off the market, leaving Pfizer's Celebrex as the only Cox-2 inhibitor drug still being sold ... Study to weigh painkillers' safety Dec 14, 2005 Seattle Times, Drug safety and the credibility of research have become bigger concerns since Vioxx and Bextra were pulled from the market because of evidence they can raise ... Simplify, Simplify Your Stocks Dec 14, 2005 Motley Fool ...stock trading around $26 in December 2004, Prudential offered a 12- to 18-month price target of $34 due to patent exposure and safety issues related to Bextra. ... Study aims to clear up confusion on painkillers Dec 13, 2005 Pittsburgh Post Gazette, ...he said. Vioxx and another drug, Bextra, were pulled from the market last year because of their potential for health risks. Both ... Pfizer gains on increase to dividend Dec 13, 2005 Providence Journal (subscription), Pfizer has also been struggling with numerous issues including patent losses, the withdrawal of its pain reliever Bextra, and staggering sales of its pain ... Scientists searching for safe pain-relief drug Dec 13, 2005 WIS, ...to know that.". Similar drugs Vioxx and Bextra were recalled because they increased the risk for heart attacks. Scientists at the ... Cleveland Clinic To Lead Large Study on Safety, Efficacy of COX-2 ... Dec 14, 2005 Kaiser network.org, September 2004 over concerns that the medication could increase risk for cardiovascular events, and Pfizer in April removed the COX-2 inhibitor Bextra from the ... Painkiller Study Aims to Answer Safety Questions Dec 14, 2005 MedPage Today, Last April, Pfizer in response to an FDA request pulled Bextra (valdecoxib), another potent Cox 2 inhibitor, from the market after reports that it, too ... Pfizer Funds $100 Million Study On Cox-2 Inhibitors Celebrex Dec 14, 2005 Medical News Today, ...heart attacks and/or strokes. Then another drug, Bextra (Pfizer) was also withdrawn for the same reason. Since then patients as ... |
|
Home Copyright phasechange.org 2006. All Rights Reserved. |